Whistleblowers say Teva used kickbacks to push up Copaxone, Azilect sales

Teva Pharmaceutical Industries ($TEVA) is facing whistleblower allegations that it used kickbacks, disguised as speaking fees, to persuade doctors to boost prescriptions of its multiple sclerosis drug Copaxone and Parkinson's med Azilect. More from FiercePharmaMarketing